XML 76 R36.htm IDEA: XBRL DOCUMENT
v2.4.1.9

Stockholders' Equity (Tables) | 2 Months Ended | 9 Months Ended | 12 Months Ended
--- | --- | --- | ---
Mar. 31, 2014 | Dec. 31, 2014 | Jan. 31, 2014
Stockholders' Equity Note [Abstract] |  |  |
Schedule of Nonvested Share Activity | A summary of the Company’s restricted stock sold to employees, directors and consultants with a right of repurchase of unlapsed or unvested shares is as follows for the two months ended March 31, 2014:
|  |  |  |  | Weighted Average Remaining Vesting |  | Weighted Average Per Share |  | Weighted- average Per Share |
|  |  |  |  | Life |  | Intrinsic |  | Grant Date |
|  | Shares |  | (In years) |  | Value |  | Fair Value |
Unvested or unlapsed shares - January 31, 2014 |  |  | 101,296 |  |  | 1.5 |  | $ | - |  | $ | 4.10 |
Granted |  |  | - |  |  | - |  |  | - |  |  | - |
Vested / lapsed |  |  | (10,555) |  |  | - |  |  | - |  |  | - |
Forfeited |  |  | - |  |  | - |  |  | - |  |  | - |
Unvested or unlapsed shares - March 31, 2014 |  |  | 90,741 |  |  | 1.3 |  | $ | - |  | $ | 4.10 |
| A summary of the Company’s restricted stock sold to employees, directors and consultants with a right of repurchase of unlapsed or unvested shares is as follows for the nine months ended December 31, 2014:
|  |  |  | Weighted Average Remaining Vesting |  | Weighted Average Per Share |  | Weighted- average Per Share |
|  |  |  | Life |  | Intrinsic |  | Grant Date |
|  | Shares |  | (In years) |  | Value |  | Fair Value |
Unvested or unlapsed shares, beginning of period |  | 90,741 |  | 1.3 |  | $ | - |  | $ | 4.10 |
Granted |  | - |  | - |  |  | - |  |  | - |
Vested / lapsed |  | (71,667) |  | - |  |  | - |  |  | - |
Forfeited |  | - |  | - |  |  | - |  |  | - |
Unvested or unlapsed shares, end of period |  | 19,074 |  | 1.1 |  | $ | 0. 90 |  | $ | 4.10 |
| A summary of the Company’s restricted stock sold to employees, directors and consultants with a right of repurchase of unlapsed or unvested shares is as follows for the year ended January 31:
|  |  |  | Weighted-average |
|  |  |  | Grant Date |
|  | Shares |  | Fair Value |
Unvested or unlapsed shares - February 1, 2012 |  | - |  | $ | - |
Granted |  | 575,000 |  |  | 3.00 |
Vested / lapsed |  | (391,482) |  |  | 3.00 |
Forfeited |  | - |  |  | - |
Unvested or unlapsed shares - January 31, 2013 |  | 183,518 |  | $ | 3.00 |
Granted |  | - |  |  | - |
Vested / lapsed |  | (82,222) |  |  | 2.10 |
Forfeited |  | - |  |  | - |
Unvested or unlapsed shares - January 31, 2014 |  | 101,296 |  | $ | 4.10 |
Fair Value Of Closing Stock Price Based On Assumptions [Table Text Block] |  |  | The calculation was based on the Company’s closing stock price on the date of grant and the following weighted-average inputs:
Expected term (in years) |  | 3.0 |
Volatility |  | 17.4 | %
Dividends |  | 0.0 | %
Interest rate |  | 0.82 | %
The calculation was based on the Company’s closing stock price on the date of grant and the following weighted-average inputs:
Exercise Price |  | $ | 4.10 |
Expected Term (in years) |  |  | 4.59 |
Volatility |  |  | 26.0 | %
Dividend rate |  |  | 0.0 | %
Interest rate |  |  | 0.5 | %
The calculation was based on the Company’s closing stock price on the date of grant and the following weighted-average inputs:
Expected term (in years) |  | 3.0 |
Volatility |  | 29.7 | %
Dividends |  | 0.0 | %
Interest rate |  | 0.5 | %
The fair value of the 40,000 stock options of $ 69,464 was determined under the Black-Scholes option pricing model using the Company’s closing stock price on the date of grant and the following weighted-average inputs:
Exercise Price |  | $ | 5.00 |
Expected Term (in years) |  |  | 3.0 |
Volatility |  |  | 29.7 | %
Dividend rate |  |  | 0.0 | %
Interest rate |  |  | 0.64 | %
Fair Value Of Options Granted Based On Assumptions [Table Text Block] |  |  | The calculation was based on the Company’s closing stock price on the date of grant and the following weighted-average inputs:
Exercise Price |  | $ | 0.04 |
Expected Term (in years) |  |  | 3.00 |
Volatility |  |  | 29.7 | %
Dividend rate |  |  | 0.0 | %
Interest rate |  |  | 0.6 | %
The calculation was based on the estimated fair value of the Company’s stock price on the date of grant and the following weighted-average inputs:
Exercise Price |  | $ | 4.70 |
Expected Term (in years) |  |  | 6.00 |
Volatility |  |  | 67.2 | %
Dividend rate |  |  | 0.0 | %
Interest rate |  |  | 1.4 | %
Stock Option Transactions Under Stock Option Plans | Stock option activity for the two months ended March 31, 2014 is summarized below:
|  | Shares |  | Weighted Average Per Share Exercise Price |  | Weighted Average Remaining Life (Years) |  | Weighted Average Per Share Intrinsic Value |
Balance, January 31, 2014 |  |  | 735,800 |  | $ | 1.70 |  |  | 9.0 |  | $ | 1.60 |
Granted |  |  | - |  |  |  |  |  |  |  |  |  |
Cancelled |  |  | (88,767) |  |  | 2.30 |  |  | 7.9 |  |  | - |
Exercised |  |  | - |  |  |  |  |  |  |  |  | - |
Expired |  |  | - |  |  |  |  |  |  |  |  | - |
Forfeited |  |  | (18,333) |  |  | 2.10 |  |  | 8.5 |  |  | - |
Balance, March 31, 2014 |  |  | 628,700 |  | $ | 2.00 |  |  | 8.7 |  | $ | 1.10 |
Vested and exercisable - March 31, 2014 |  |  | 526,089 |  | $ | 1.90 |  |  | 7.3 |  | $ | 1.20 |
| Stock option activity for the nine months ended December 31, 2014 is summarized below:
|  | Shares |  | Weighted Average Per Share Exercise Price |  | Weighted Average Remaining Life (Years) |  | Weighted Average Per Share Intrinsic Value |
Balance, beginning of period |  | 628,700 |  | $ | 2.00 |  | 8.7 |  | $ | 1.10 |
Granted |  | 85,500 |  |  | 10.00 |  | - |  |  | - |
Cancelled |  | (10,000) |  |  | - |  | - |  |  | - |
Exercised |  | - |  |  | - |  | - |  |  | - |
Expired |  | - |  |  | - |  | - |  |  | - |
Forfeited |  | - |  |  | - |  | - |  |  | - |
Balance, end of period |  | 704,200 |  | $ | 2.60 |  | 8.2 |  | $ | 1.50 |
Vested and exercisable, end of period |  | 623,256 |  | $ | 2.20 |  | 7.3 |  | $ | 1.80 |
| Stock option activity for the years ended January 31, 2014 and 2013 is summarized below:
01 |  | Shares |  | Weighted Average Per Share Exercise Price |  | Weighted Average Remaining Life (Years) |  | Aggregate Intrinsic Value |
Balance, February 1, 2012 |  |  | 115,000 |  | $ | 1.50 |  |  | 8.9 |  | $ | - |
Granted |  |  | 422,500 |  |  | 1.90 |  |  | 9.2 |  |  | - |
Exercised |  |  | (7,500) |  |  | 2.10 |  |  | - |  |  | - |
Expired |  |  | - |  |  | - |  |  | - |  |  | - |
Forfeited |  |  | - |  |  | - |  |  | - |  |  | - |
Balance, January 31, 2013 |  |  | 530,000 |  |  | 1.79 |  |  | 9.1 |  | $ | - |
Granted |  |  | 308,500 |  |  | 1.80 |  |  | 9.4 |  |  | - |
Cancelled |  |  | (102,025) |  |  | 2.22 |  |  | 8.6 |  |  | - |
Exercised |  |  | - |  |  | - |  |  | - |  |  | - |
Expired |  |  | - |  |  | - |  |  | - |  |  | - |
Forfeited |  |  | (675) |  |  | 7.90 |  |  | 9.0 |  |  | - |
Balance, January 31, 2014 |  |  | 735,800 |  | $ | 1.71 |  |  | 9.0 |  | $ | - |
Vested and exercisable - January 31, 2014 |  |  | 606,689 |  | $ | 1.60 |  |  | 9.1 |  | $ | - |
Summary of Restricted Stock Award | The following table summarizes the restricted stock award in the ACO Plan during the two months ended March 31, 2014:
|  | Shares |  | Weighted Average Remaining Vesting Life (Years) |  | Weighted Average Per Share Intrinsic Value |  | Weighted Average Per Share Fair Value |
Balance, January 31, 2014 |  |  | 3,752,000 |  |  | 1.0 |  | $ | 0.02 |  | $ | 0.03 |
Granted |  |  | - |  |  | - |  |  | - |  |  | - |
Released |  |  | - |  |  | - |  |  | - |  |  | - |
Balance, March 31, 2014 |  |  | 3,752,000 |  |  | 0.8 |  | $ | 0.02 |  | $ | 0.03 |
Vested and exercisable - March 31, 2014 |  |  | 2,480,042 |  |  |  |  |  |  |  |  |  |
| The following table summarizes the restricted stock award in the ACO Plan during the nine months ended December 31, 2014:
|  | Shares |  | Weighted Average Remaining Vesting Life (Years) |  | Weighted Average Per Share Intrinsic Value |  | Weighted Average Per Share Fair Value |
Balance, beginning of period |  | 3,752,000 |  | 0.8 |  | $ | 0.02 |  | $ | 0.03 |
Granted |  | 184,000 |  | - |  |  | - |  |  | 0.77 |
Released |  | (183,996) |  | - |  |  | - |  |  | - |
Balance, end of period |  | 3,752,004 |  | 0.1 |  | $ | 0.70 |  | $ | 0.07 |
Vested and exercisable, end of period |  | 2,461,694 |  |  |  |  |  |  |  |  |
| The following table summarizes the restricted stock award in the ACO Plan during the years ended January 31, 2014 and 2013:
|  | Shares |  | Weighted Average Remaining Life (Years) |  | Aggregate Intrinsic Value |  | Weighted Average Fair Value |
Balance, February 1, 2012 |  |  | - |  |  | - |  | $ | - |  |  | - |
Granted |  |  | 3,690,000 |  |  | 1.9 |  |  | 36,900 |  |  | 0.01 |
Released |  |  |  |  |  |  |  |  |  |  |  |  |
Balance, January 31, 2013 |  |  | 3,690,000 |  |  | 1.9 |  |  | 36,900 |  |  | 0.01 |
Granted |  |  | 62,000 |  |  | 1.7 |  |  | 620 |  |  | 0.01 |
Released |  |  | - |  |  |  |  |  |  |  |  |  |
Balance, January 31, 2014 |  |  | 3,752,000 |  |  | 1.0 |  | $ | 37,520 |  | $ | 0.01 |
Vested and exercisable - January 31, 2014 |  |  | 2,480,042 |  |  |  |  |  |  |  |  |  |
Total Unrecognized Compensation Costs Related To Non-Vested Stock-Based Compensation Arrangements | As of March 31, 2014, total unrecognized compensation costs related to non-vested stock-based compensation arrangements granted under the Company’s 2010 and 2013 Equity Plans, and the ACO Plan’s and the weighted-average period of years expected to recognize those costs are as follows:
Common stock options |  | $ | 99,732 |
Restricted stock |  | $ | 201,380 |
ACO Plan restricted stock |  | $ | 10,525 |
| As of December 31, 2014, total unrecognized compensation costs related to non-vested stock-based compensation arrangements granted under the Company’s 2010 and 2013 Equity Plans, and the ACO Plan’s and the weighted-average period of years expected to recognize those costs are as follows:
Common stock options |  | $ | 193,376 |
Restricted stock |  | $ | 139,400 |
ACO Plan restricted stock |  | $ | 48,846 |
| As of January 31, 2014, total unrecognized compensation costs related to non-vested common stock options granted under our 2010 and 2013 Equity Plans, and the ACO Plan and the weighted-average period of years expected to recognize those costs are as follows:
|  |  |  |  | Weighted |
|  |  |  |  | Average |
|  |  |  |  | Remaining |
|  |  |  |  | Life |
|  |  |  |  | (Years) |
Common stock options |  | $ | 118,194 |  |  | 0.8 |
ACO Plan restricted stock |  | $ | 15,736 |  |  | 1.0 |
Summary of Stock Based Compensation Expense Related To Restricted Stock and Option Awards | Stock-based compensation expense related to common stock and common stock option awards is recognized over their respective vesting periods and was included in the accompanying condensed consolidated statement of operations as follows:
|  | Two months ended March 31, |
|  | 2014 |  | 2013 |
Stock-based compensation expense: |  |  |  |  |  |  |
Cost of services |  | $ | 15,703 |  | $ | 14,077 |
General and administrative |  |  | 44,484 |  |  | 31,209 |
|  | $ | 60,187 |  | $ | 45,286 |
| Stock-based compensation expense related to common stock and common stock option awards is recognized over their respective vesting periods and was included in the accompanying condensed consolidated statement of operations as follows:
|  | Three Months Ended December 31, |  | Nine Months Ended December 31, |
|  | 2014 |  | 2013 |  | 2014 |  | 2013 |
Stock-based compensation expense: |  |  |  |  |  |  |  |  |  |  |  |  |
Cost of services |  | $ | 1,227 |  | $ | 54,134 |  | $ | 12,148 |  | $ | 629,643 |
General and administrative |  |  | 155,325 |  |  | (76,338) |  |  | 1,120,062 |  |  | 1,469,165 |
|  | $ | 156,552 |  | $ | (22,204) |  | $ | 1,132,210 |  | $ | 2,098,808 |
| Stock-based compensation expense related to common stock and common stock option awards is recognized over their respective vesting periods and was included in the accompanying consolidated statement of operations for the years ended January 31:
|  | 2014 |  | 2013 |
Stock-based compensation expense: |  |  |  |  |  |  |
Cost of services |  | $ | 616,902 |  | $ | 550,710 |
General and administrative |  |  | 1,540.955 |  |  | 1,511,018 |
|  | $ | 2,157,857 |  | $ | 2,061,728 |
Warrants Outstanding | Warrants consisted of the following as of and for the two months ended March 31, 2014:
|  | Weighted Average Per Share |  |  |
|  | Intrinsic |  | Number of |
|  | Value |  | warrants |
Outstanding at February 1, 2014 |  | $ | 0.40 |  |  | 314,500 |
Granted |  |  | - |  |  | 400,000 |
Exercised |  |  | - |  |  | - |
Cancelled |  |  | - |  |  | - |
Outstanding at March 31, 2014 |  | $ | 0.20 |  |  | 714,500 |
|  |  |  |  |  | Weighted |  |  |  |  |  |  |
|  |  |  |  |  | average |  |  |  |  | Weighted |
Exercise Price Per |  | Warrants |  | remaining |  | Warrants |  | average |
Share |  | outstanding |  | contractual life |  | exercisable |  | exercise price per share |
$ | 1.1485 |  |  | 125,000 |  |  | 2.50 |  |  | 125,000 |  | $ | 1.149 |
$ | 1.1485 |  |  | 25,000 |  |  | 2.50 |  |  | 25,000 |  | $ | 1.149 |
$ | 4.5000 |  |  | 50,000 |  |  | 2.50 |  |  | 50,000 |  | $ | 4.500 |
$ | 5.0000 |  |  | 10,000 |  |  | 3.74 |  |  | 10,000 |  | $ | 5.000 |
$ | 4.5000 |  |  | 82,500 |  |  | 4.00 |  |  | 82,500 |  | $ | 4.500 |
$ | 4.0000 |  |  | 22,000 |  |  | 4.00 |  |  | 22,000 |  | $ | 4.000 |
$ | 10.0000 |  |  | 200,000 |  |  | 7.00 |  |  | - |  | $ | 10.000 |
$ | 20.0000 |  |  | 200,000 |  |  | 7.00 |  |  | - |  | $ | 20.000 |
|  |  |  | 714,500 |  |  | 5.26 |  |  | 314,500 |  |  | 2.900 |
| Warrants consisted of the following for the nine months ended December 31, 2014:
|  | Weighted Average Per Share |  |  |
|  | Intrinsic |  | Number of |
|  | Value |  | warrants |
Outstanding, beginning of period |  | $ | 2.00 |  | 714,500 |
Granted |  |  | - |  | 200,000 |
Exercised |  |  | - |  | - |
Cancelled |  |  | - |  | - |
Outstanding, end of period |  | $ | - |  | 914,500 |
|  |  |  |  | Weighted |  |  |  | Weighted |
|  |  |  |  | average |  |  |  | average |
Exercise Price Per |  | Warrants |  | remaining |  | Warrants |  | exercise price per |
Share |  | outstanding |  | contractual life |  | exercisable |  | share |
$ | 1.1485 |  | 125,000 |  | 1.6 |  | 125,000 |  | $ | 1.149 |
$ | 1.1485 |  | 25,000 |  | 1.6 |  | 25,000 |  | $ | 1.149 |
$ | 4.5000 |  | 50,000 |  | 1.6 |  | 50,000 |  | $ | 4.500 |
$ | 5.0000 |  | 10,000 |  | 2.8 |  | 10,000 |  | $ | 5.000 |
$ | 4.5000 |  | 82,500 |  | 3.1 |  | 82,500 |  | $ | 4.500 |
$ | 4.0000 |  | 22,000 |  | 3.1 |  | 22,000 |  | $ | 4.000 |
$ | 10.0000 |  | 200,000 |  | 6.2 |  | - |  | $ | 10.000 |
$ | 20.0000 |  | 200,000 |  | 6.2 |  | - |  | $ | 20.000 |
$ | 10.0000 |  | 100,000 |  | 6.2 |  | - |  | $ | 10.000 |
$ | 10.0000 |  | 100,000 |  | 3.6 |  | 100,000 |  | $ | 10.000 |
|  |  | 914,500 |  | 4.5 |  | 414,500 |  |  | 4.600 |
| Warrants consisted of the following:
|  | Aggregate |  |  |  |
|  | Intrinsic |  | Number of |
|  | Value |  | warrants |
Outstanding at February 1, 2012 |  | $ | - |  |  | 150,000 |
Granted |  |  | - |  |  | 293,600 |
Exercised |  |  | - |  |  |  |
Cancelled |  |  | - |  |  | (150,000) |
Outstanding at January 31, 2013 |  | $ | - |  |  | 293,600 |
Granted |  |  | - |  |  | 20,900 |
Exercised |  |  | - |  |  | - |
Cancelled |  |  | - |  |  | - |
Outstanding at January 31, 2014 |  | $ | - |  |  | 314,500 |
|  |  |  | Weighted |  |  |  |  |
|  |  |  | average |  |  |  | Weighted |
|  | Warrants |  | remaining |  | Warrants |  | average |
Exercise Price |  | outstanding |  | contractual life |  | exercisable |  | exercise price |
$ | 1.1485 |  |  | 125,000 |  |  | 2.50 |  |  | 125,000 |  | $ | 1.149 |
$ | 1.1485 |  |  | 25,000 |  |  | 2.50 |  |  | 25,000 |  | $ | 1.149 |
$ | 4.5000 |  |  | 50,000 |  |  | 2.50 |  |  | 50,000 |  | $ | 4.500 |
$ | 5.0000 |  |  | 10,000 |  |  | 3.74 |  |  | 10,000 |  | $ | 5.000 |
$ | 4.5000 |  |  | 82,500 |  |  | 4.00 |  |  | 82,500 |  | $ | 4.500 |
$ | 4.0000 |  |  | 22,000 |  |  | 4.00 |  |  | 22,000 |  | $ | 4.000 |
|  |  |  | 314,500 |  |  | 3.04 |  |  | 314,500 |  | $ | 2.882 |
Amount of Shares of Common Stock Reserved | The amount of shares of common stock reserved for these purposes is as follows at March 31, 2014:
Common stock issued and outstanding |  | 4,913,455 |
Conversion of 9% Notes |  | 275,000 |
Warrants outstanding |  | 714,500 |
Stock options outstanding |  | 628,700 |
Remaining shares issuable under 2013 Equity Incentive Plan |  | 270,700 |
|  | 6,802,355 |
| The amount of shares of common stock reserved for these purposes is as follows at December 31, 2014:
Common stock issued and outstanding |  | 4,863,455 |
Conversion of 9% Notes |  | 275,000 |
Conversion of 8% Notes |  | 200,000 |
Warrants outstanding |  | 914,500 |
Stock options outstanding |  | 704,200 |
Remaining shares issuable under 2013 Equity Incentive Plan |  | 160,000 |
|  | 7,117,155 |
| The amount of shares of common stock reserved for these purposes is as follows at January 31, 2014:
Common stock issued and outstanding |  |  | 4,695,247 |
Conversion of 8% Notes (1) |  |  | 18,208 |
Conversion of 9% Notes |  |  | 275,000 |
Warrants outstanding |  |  | 314,500 |
Stock options outstanding |  |  | 735,800 |
Remaining shares issuable under 2013 Equity Incentive Plan |  |  | 182,000 |
Shares and warrants issued in March 2014 (2) |  |  | 600,000 |
|  |  | 6,820,755 |
(1) Reflects shares issued in February 2014 in connection with the conversion of the 8% notes. See Note 10. (2) Reflects 200,000 shares and 400,000 warrants issued in March 2014 in connection with an equity investment. See Note 10.

X
- Definition No authoritative reference available. + References No definition available. + Details
Name: | ameh_FairValueOfClosingStockPriceBasedOnAssumptionsTableTextBlock
Namespace Prefix: | ameh_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition No authoritative reference available. + References No definition available. + Details
Name: | ameh_FairValueOfOptionsGrantedBasedOnAssumptionsTableTextBlock
Namespace Prefix: | ameh_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Schedule Of Common Stock Reserved For Future Issuance [Table Text Block] + References No definition available. + Details
Name: | ameh_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock
Namespace Prefix: | ameh_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the changes in outstanding nonvested restricted stock shares. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 + Details
Name: | us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the amount of total share-based compensation cost, including the amounts attributable to each share-based compensation plan and any related tax benefits. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for share options (or share units) that were outstanding at the beginning and end of the year, vested and expected to vest, exercisable or convertible at the end of the year, and the number of share options or share units that were granted, exercised or converted, forfeited, and expired during the year. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(i)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph i -Article 4 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6406099&loc=d3e25284-112666 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -Section S99 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 28 -Article 5 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the total compensation cost related to nonvested awards not yet recognized and the weighted-average period over which it is expected to be recognized. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (i) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration